- Home
- Publications
- Publications Database
-
Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
This page provides detailed information about this publication. Please click on any text which is underlined to find more information.
- Authors
- Ronald N. Marcus, Randall Owen, George Manos, Raymond Mankoski, L. Kamen, Robert D. McQuade, William H. Carson, Robert L. Findling
- Title
- Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
- Journal
- Journal of Clinical Psychiatry
- Year
- 2011
- Volume
- 72
- Issue
- 9
- Page(s)
- pp. 1270-1276.
- Abstract Link
- Read Abstract (New Window)
- Publication Format
- Journal Article
- Efficacy Study/Review
- Yes
- Scientific Validity
- Peer-Reviewed, Open Trial
- Comments
This is a secondary analysis of Marcus R. N. et al. (2011) Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.
- Keywords
- Antipsychotics, Aripiprazole, Atypical, Autism, Autistic Disorder, Intervention, Irritability, Medication, Psychoactive
-
Marcus R. N.
et al.
(2011)
Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.
Journal of Child and Adolescent Psychopharmacology.
21(3),
Read Abstract
(New Window)
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.